HeberFERON, a new formulation of IFNs with improved pharmacodynamics: Perspective for cancer treatment

I Bello-Rivero, Y Garcia-Vega, Y Duncan-Roberts… - Seminars in …, 2018 - Elsevier
The rational combination of recombinant IFN-α2b and IFN-γ resulted in a new formulation of
interferons (HeberFERON) with improved pharmacodynamics. In basal cell carcinomas …

[HTML][HTML] Treatment of basal cell carcinoma with interferons alpha-2b and gamma in primary care

…, I Bello-Rivero, Y Duncan-Roberts - MEDICC …, 2018 - SciELO Public Health
INTRODUCTION Interferons have been used to treat basal cell carcinoma with positive
results. Cuba’s Genetic Engineering and Biotechnology Center developed HeberPAG, a …

[PDF][PDF] HeberFERON, formulation based on IFNs alpha2b and gamma for the treatment of non-melanoma skin cancer.

…, K Batista, Y Duncan-Roberts… - Australasian Medical …, 2017 - researchgate.net
Background Surgery remains the procedure of election for the treatment of non-melanoma
skin cancer (NMSC). However, after recurrence, or under surgical complex scenarios, other …

[HTML][HTML] Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma …

…, N Castro-Basart, Y Duncan-Roberts… - BMC Pharmacology and …, 2012 - Springer
Background The synergistic combination of interferon (IFN) alpha-2b and IFN gamma results
in more potent in vitro biological effects mediated by both IFNs. The aim of this investigation …

Basal cell carcinoma treated with HeberFERON. A real world retrospective study

…, R Hernández-Rodriguez, Y Duncan-Roberts… - medRxiv, 2021 - medrxiv.org
Background Basal cell carcinoma is the most common type of skin cancer with major impact
in health-related quality of life. The use of the formulation based on the combination of IFN-…

Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA. Preliminary results of a …

…, J Pérez-Escribano, Y Duncan-Roberts… - medRxiv, 2020 - medrxiv.org
Objectives An IFN-α2b and IFN-γ combination has demonstrated favorable pharmacodynamics
for genes underlying antiviral activity which might be involved in the defense of a host …

Five years follow-up of patients with non-melanoma skin cancer treated with HeberFERON

Y Duncan-Roberts, Y Garcia-Vega… - medRxiv, 2022 - medrxiv.org
Introduction Non-melanoma skin cancer is the most common tumor. The combination of IFN-alpha
2b and IFN-gamma has been used as a new therapeutic opportunity to treat basal cell …

[HTML][HTML] Seguridad del HeberFERON (en pacientes con carcinoma basal palpebral

…, I Bello Rivero, Y Duncan Roberts - Revista Cubana de …, 2021 - scielo.sld.cu
y 79 años de edad (80 %) y las lesiones se presentaron fundamentalmente en el párpado
inferior (60 (). El eritema palpebral y … (95,0 y 70,0 % respectivamente) y se presentaron en el …

The role of the colonic microbiota and bile acids in colorectal cancer

DC Roberts, S Chidambaram… - Current Opinion in …, 2022 - journals.lww.com
… Gao J, He J, Zhai Y, et al. The constitutive androstane receptor is an antiobesity nuclear
receptor that improves in sulin sensitivity. J Biol Chem 2009; 284:25984–25992. … Feng Y …

[PDF][PDF] Heberferon May Contain The SARS-Cov-2 Infection

IB Rivero, Y Duncan-Roberts… - Biomedical Journal of …, 2020 - researchgate.net
Introduction Human coronavirus is an important agent causing mild-tosevere respiratory tract
infections in humans. It is clear that viral dissemination is determinant in the establishment …